Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

16
Number of overlapping holdings
39.0%
% of HRTS's 41 holdings also in FMED
28.6%
% of FMED's 61 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HRTS |
Weight in FMED |
Overlap | |
---|---|---|---|---|
UNITEDHEALTH GROUP INC | 6.1% | 4.1% | 4.1% | |
BOSTON SCIENTIFIC CORP | 3.0% | 6.6% | 3.0% | |
ALNYLAM PHARMACEUTICALS INC | 2.2% | 2.7% | 2.2% | |
EDWARDS LIFESCIENCES CORP | 2.0% | 2.3% | 2.0% | |
INSULET CORP | 1.9% | 4.5% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to FMED
ELI LILLY & CO | 7.5% | |
BRIDGEBIO PHARMA, INC. | 4.5% | |
NOVO NORDISK A/S-B | 3.9% | |
ASTRAZENECA PLC | 3.8% | |
MERCK & CO. INC. | 3.6% | |
ROCHE HOLDINGS LTD-SPONS ADR | 3.5% | |
ABBOTT LABORATORIES | 3.3% | |
CHUGAI PHARMACEUTICAL CO LTD | 3.0% | |
AMGEN INC | 2.8% | |
VERTEX PHARMACEUTICALS INC | 2.8% |
HRTS Underweight Relative to FMED
INTUITIVE SURGICAL INC | -4.6% | |
BOSTON SCIENTIFIC CORP | -3.7% | |
ARGENX SE ADR | -3.6% | |
EXACT SCIENCES CORP | -3.2% | |
PENUMBRA, INC. | -2.8% | |
UCB SA | -2.8% | |
STRYKER CORP | -2.7% | |
INSULET CORP | -2.7% | |
LIFESTANCE HEALTH GROUP, INC. | -2.6% | |
LEGEND BIOTECH CORPORATION SPONSORED | -2.3% |